- Home
- ANGO vs LIEN Comparison
ANGO vs LIEN Comparison
Compare ANGO & LIEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGO
- LIEN
- Stock Information
- Founded
- ANGO 1988
- LIEN 2021
- Country
- ANGO United States
- LIEN United States
- Employees
- ANGO N/A
- LIEN N/A
- Industry
- ANGO Medical/Dental Instruments
- LIEN
- Sector
- ANGO Health Care
- LIEN
- Exchange
- ANGO Nasdaq
- LIEN NYSE
- Market Cap
- ANGO 401.4M
- LIEN 264.8M
- IPO Year
- ANGO 2004
- LIEN 2022
- Fundamental
- Price
- ANGO $10.18
- LIEN $11.31
- Analyst Decision
- ANGO Strong Buy
- LIEN
- Analyst Count
- ANGO 3
- LIEN 0
- Target Price
- ANGO $13.00
- LIEN N/A
- AVG Volume (30 Days)
- ANGO 538.4K
- LIEN 10.8K
- Earning Date
- ANGO 04-02-2025
- LIEN 05-08-2025
- Dividend Yield
- ANGO N/A
- LIEN 11.97%
- EPS Growth
- ANGO N/A
- LIEN N/A
- EPS
- ANGO N/A
- LIEN 0.67
- Revenue
- ANGO $286,498,000.00
- LIEN $12,681,914.00
- Revenue This Year
- ANGO N/A
- LIEN $71.81
- Revenue Next Year
- ANGO $6.63
- LIEN $113.93
- P/E Ratio
- ANGO N/A
- LIEN $17.03
- Revenue Growth
- ANGO N/A
- LIEN 22.94
- 52 Week Low
- ANGO $5.30
- LIEN $8.38
- 52 Week High
- ANGO $13.50
- LIEN $13.38
- Technical
- Relative Strength Index (RSI)
- ANGO 56.17
- LIEN N/A
- Support Level
- ANGO $9.34
- LIEN N/A
- Resistance Level
- ANGO $9.84
- LIEN N/A
- Average True Range (ATR)
- ANGO 0.45
- LIEN 0.00
- MACD
- ANGO 0.17
- LIEN 0.00
- Stochastic Oscillator
- ANGO 94.55
- LIEN 0.00
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
About LIEN CHICAGO ATLANTIC BDC INC
Chicago Atlantic BDC Inc is a specialty finance company. The company's investment objective is to maximize risk-adjusted returns on equity for its stockholders by investing primarily in direct loans to privately held middle-market companies, with a focus on cannabis companies.